MC
IMGN

Maverick Capital’s Immunogen Inc IMGN Stock Holding History

Maverick Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,493,217
Closed -$73.9M – 572
2023
Q4 		$73.9M Sell
2,493,217
-25,310
-1% -$504K 1.48% 21
2023
Q3 		$40M Sell
2,518,527
-1,268,371
-33% -$21.1M 0.9% 27
2023
Q2 		$71.5M Sell
3,786,898
-4,069,511
-52% -$48M 1.52% 18
2023
Q1 		$30.2M Buy
7,856,409
+977,466
+14% +$4.17M 0.76% 29
2022
Q4 		$34.1M Buy
6,878,943
+3,325,815
+94% +$18M 0.81% 31
2022
Q3 		$17M Buy
3,553,128
+786,654
+28% +$4.15M 0.38% 43
2022
Q2 		$12.4M Buy
+2,766,474
New +$12M 0.31% 48

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Maverick Capital's IMGN Position: Q1 2024 in Review

Maverick Capital sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 2,493,217 shares — an estimated $73.9M sold.

Maverick Capital first reported a position in IMGN in Q2 2022 and held it in 7 quarters. The position peaked at $73.9M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Maverick Capital reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Maverick Capital sold 2,493,217 Immunogen Inc shares in Q1 2024, an estimated $73.9M.
  • Maverick Capital first reported a position in Immunogen Inc in Q2 2022 and held it in 7 quarters.
  • Maverick Capital's Immunogen Inc position peaked at $73.9M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Maverick Capital's 13F filing for Q1 2024, filed 15 May 2024.